Corindus Vascular Robotics (CVRS) Stock Price, News & Analysis

Company Overview

Corindus Vascular Robotics was a medical technology company that developed robotic-assisted systems for interventional vascular procedures. Its technology was designed to help physicians perform minimally invasive treatments while improving procedural control, precision and ergonomics.

The company’s primary product was the CorPath GRX platform, a robotic system used in procedures including percutaneous coronary intervention (PCI) and peripheral vascular interventions. The platform enabled physicians to control interventional devices from a workstation and was intended to support accurate device navigation while reducing occupational exposure to radiation.

Corindus marketed its technology to hospitals and medical centers in the United States and international markets. The company was acquired by Siemens Healthineers in 2019, after which Corindus became part of Siemens Healthineers’ broader image-guided therapy and interventional robotics activities. As a result, Corindus Vascular Robotics is no longer an independent publicly traded company under the NYSE American ticker CVRS.

Key Stats

• Today's Range: $4.27 to $4.27
• 50-Day Range: $4.27 to $4.27
• 52-Week Range: $0.78 to $4.40
• Volume: N/A
• Average Volume: 1.99 million shs
• Market Capitalization: $891.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 8/07/2018
• Today: 10/15/2026

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSEAMERICAN:CVRS
• Previous Symbol: NYSEMKT:CVRS
• CIK: N/A
• Web: www.corindus.com
• Phone: +1-508-6533335
• Fax: N/A
• Employees: 90
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 208,685,000
• Free Float: N/A
• Market Cap: $891.08 million
• Optionable: Not Optionable
• Beta: N/A